Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Targeted small tissue may restore skin function by reconnecting surviving tissue

Small of a person's own tissue might restore function across a skin region by reconnecting surviving tissue. placed at selected connections versus random or would test this; benefit confined to grafted tissue or determined only by total volume would reject it.

Stage of verification

  1. Hypothesis published2026-09-26
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionSkin

Ageing mechanism

Main connectionAltered intercellular communication

Direction

Kind of knowledge gap

No current scientific result answers this requirement.Void gap

A double ring marks the main placement where a group contains several values.

Lens
Candidate set selection
Goal
Идентификация терапии с десятилетним восстановлением функций кожи
Competing hypotheses
1
Published
2026-09-26
As a hypothesis
8 / 10Clarity of mechanism
6 / 10Few extra conditions
9 / 10Completeness of the answer
6 / 10Novelty of the idea
8 / 10Few new entities
8 / 10Decisive experiment
3 / 10Silver-bullet potential
4 / 10Support from research
Poster: Micrografts target skin connection gaps
PosterOpen the sheet full size2026-09-26

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Organ structure

    Skin tissue

    Tissue comprising the epidermis, dermis and , with vascular and nerve connections

    Where this hypothesis actsSites of broken connections between retained functional regions of the epidermis, dermis and

    Hypotheses on this target 4
    Skin tissueFunction restoration. Hypotheses on this target 22Remodelling. Hypotheses on this target 0Tissue graft. Hypotheses on this target 22Load normalisation. Hypotheses on this target 0
    • Function restoration2
    • Remodelling
    • Tissue graft2
    • Load normalisation

    What is proposed

    Tissue graft

    Replace the minimum set of tissue sites needed to reconnect functional regions

    With whatPhysical or surgical intervention

    HowPlace complete using a tissue map, replacing ≤10% of regional skin volume; assess annually and replace disconnected sites at ≤1% per year

    Possible result

    Possible restoration of coordinated skin function across the region, including the retained ≥90% of tissue

    From the recordМинимальный набор составляет адресное замещение небольшого числа соединительных тканевых участков полноценными аутологичными микротрансплантатами.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and beddingSkin tissue. Hypotheses on this target 4Skin tissue
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Older skin might recover useful abilities if its surviving parts could work together again. The unexpected move is to replace small while retaining at least 90% of the original tissue, rather than rebuilding the supporting material throughout the region. This is a proposal generated by the pipeline, not a measured restoration of youthful skin function.

The proposed mechanism, link by link
  1. Breaks between otherwise functioning skin regions are proposed to prevent those regions from working together.
  2. A map of , , blood-vessel connections and nerve connections identifies the sites whose replacement could reconnect the region.
  3. Small made from the recipient's own tissue replace those sites and join the surviving tissue.
  4. Previously isolated regions are proposed to become a jointly functioning region, allowing improvement to extend into tissue that received no .
  5. Annual checks identify renewed losses of connection, and limited replacement is proposed to preserve the restored function for ten years.
A picture for it

A town can contain working homes and shops yet function badly because a few bridges are missing. Rebuilding the bridges could reconnect many places while replacing very little of the town.

Where the picture breaks: Living skin requires several kinds of connection at once, and a visible connection need not carry useful activity. The picture does not establish that surviving aged tissue can perform youthfully once connected, or that small repairs can maintain that performance for ten years.

  1. Master questionstep 01 of 04

    Skin in middle-aged people is intended to regain the functional condition of skin in young people.

    Rests on: The stated goal is to develop a treatment that restores skin function to a youthful level.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Restored skin function is intended to last ten years.

    Rests on: The original goal supplies the target of youthful function, but no required duration.

    Assumption

    Ten years is adopted as the required duration; the master question does not specify it.

  3. Gap questionstep 03 of 04

    A minimal treatment combination, with maintenance if needed, must keep all skin functions within a in the same participants for ten years. Its components must withstand tests that randomly omit individual components and compare outcomes with standard care.

    Rests on: The preceding goal supplies ten-year restoration. This stage turns that goal into requirements for simultaneous recovery, treatment minimality and controlled comparisons.

    Assumption

    The requirement that every skin function remain youthful in the same participants, and the requirement to establish a minimal combination through , are adopted here rather than established by the preceding goal.

  4. Hypothesisstep 04 of 04

    Small made from the recipient's own tissue are proposed to reconnect surviving skin regions. They would contain cells that renew the surface, build supporting tissue, form and support blood vessels, and supply local structures such as and , together with structures for joining the recipient's nerves. Initial would occupy at most 10% of each studied region's skin volume; annual assessment could lead to further replacement of confirmed disconnected sites, capped at 1% of the original volume per year.

    Rests on: The preceding stage calls for a minimal combination and a maintenance schedule. The proposed answer explicitly borrows mathematics about how connections allow a network to function across several kinds of links, using a measured map to select replacement sites; applying that approach to skin is identified as a proposed transfer.

    Stated in the chain

What is carried, and what is not. Of the five mechanism links above, one has partial experimental backing in the supplied sources: . Materials Today Bio (2024), source S2, reported nerve entry, small blood vessels and surface closure after implantation in mouse skin wounds, but did not establish targeted reconnection of aged human skin; no supplied source establishes the proposed sequence end to end, its volume limits or its ten-year sufficiency.S2

Where the reasoning is carried by something unstated · 2
  • Goal pillar. Ten years is adopted as the required duration; the master question does not specify it.
  • Gap question. The requirement that every skin function remain youthful in the same participants, and the requirement to establish a minimal combination through , are adopted here rather than established by the preceding goal.
How a result here could mislead · 3
  • Better outcomes at selected sites could reflect sites that support survival better, rather than repair of connections that control function across the region. Matching composition and volume alone would not separate these explanations. What closes it: The site map must be fixed before treatment, and survival and actual restoration of connections must be measured alongside function. The proposed comparisons with random placement and placement at damaged sites that are unnecessary for must also measure function separately in grafted and ungrafted tissue.
  • A more connected tissue map could be mistaken for restored skin function, or an average improvement could conceal functions that remain below the . What closes it: The proposal already requires independent checks of biological connections and joint function. The must be set using an independent young reference before treatment, and the functions and used to judge success must also be specified in advance and assessed in the same participants.
  • Failure after targeted placement could be credited to a false mechanism when the never established the intended connections. Conversely, failure of the rival treatment could be credited to a need for when that treatment never restored the supporting material as intended. What closes it: Both interventions require confirmation that they achieved their immediate targets. A comparison with the rival must verify restoration of the , the material outside cells that supports and organizes tissue, and determine whether the proposed connection breaks remain; equivalent standard care and observation periods are needed to interpret differences.

What would make this wrong. With survival and the intended connections confirmed, improvement confined to grafted tissue, or improvement determined only by volume rather than placement, would contradict the central reconnection claim. Full restoration by the rival treatment without transplanted cells, while the proposed connection breaks remained, would refute the claimed necessity of the set. Failure to sustain all required functions for ten years within the stated initial and annual replacement limits would refute the proposed regimen's sufficiency, even if short-term reconnection worked.

What it would change. If the proposal held, restoring youthful skin function would require identifying which small sites reconnect surviving tissue, and minimality would depend on where tissue is replaced as well as how much is replaced. Broad replacement of the would not be necessary under the conditions where this approach succeeded. Success in organized would still leave youthful function in middle-aged people and ten-year durability unestablished; the supplied record also does not establish that a complete human with all the required structures and functional nerve connections is ready for use.

Sources read · 7

4 literature searches, 8 full texts, 2 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S2Partly answers it

Rapid innervation and physiological epidermal regeneration by bioengineered dermis implanted in mouse. · Materials today. Bio · 2024

“Upon implantation in a mouse full-thickness skin defect model, we observed a very early innervation of the graft in 2 weeks. In addition, mouse capillaries and complete epithelialization were detectable as early as 1 week after implantation and, skin appendages developed in 2 weeks.”

Does not settle: Источник описывает предваскуляризированную дерму в модели полнослойного дефекта кожи мыши. Он не устанавливает эффективность аутологичных микротрансплантатов у человека, их полный клеточный состав, соединение с чувствительными и вегетативными нервами, минимальное число участков по карте связей, пределы 10% и 1% в год, ежегодную замену или достаточность сохранения 90% ткани.

S4Partly answers it

Back Grafting the Split-Thickness Skin Graft Donor Site. · Journal of burn care & research : official publication of the American Burn Association · 2017

“Out of the 17 patients who received this procedure, 1 patient had a complication from the procedure that did not require an operation, and all patients appear to have good functional and cosmetic outcomes.”

Does not settle: Источник описывает покрытие донорских ран расщеплённым кожным трансплантатом у 17 пациентов. Он не устанавливает состав аутологичных микротрансплантатов, восстановление нервных соединений, выбор участков по карте связей, предел в 10% объёма ткани, минимальное число участков, ежегодный режим повторного замещения или достаточность сохранения 90% ткани.

S5Partly answers it

CD133 defines hair-inductive cells in the dermal papilla. · Scientific reports · 2025

“To improve TESS functions, cells with appendage-inducing capabilities, such as DP fibroblasts located at the base of each HF, are needed.”

Does not settle: Источник описывает способность CD133+ клеток дермального сосочка мыши индуцировать волосяные фолликулы в модели реконструкции кожи. Он не устанавливает состав, объём или число аутологичных микротрансплантатов, восстановление нервных или сосудистых связей, пороги 10% и 1%, сохранение 90% ткани, критерий n* либо достаточность такого подхода для восстановления функции кожи человека.

S7Contradicts it

Mid- to Long-term Outcomes After Split-thickness Skin Graft vs. Skin Extension by Multiple Incisions. · In vivo (Athens, Greece) · 2019

“The scar was thinner, less elastic and did not provide intact sensibility.”

Does not settle: This study does not test targeted autologous micrografts, reconnection with host nerves or appendages, a connectivity-based site map, or the proposed 10% and 1% volume limits.

S8Background

Biomechanical and aesthetic outcomes following radial forearm free flap transfer: comparison of ipsilateral full-thickness skin graft and traditional split-thickness skin graft. · International journal of oral and maxillofacial surgery · 2024

“The primary outcomes were biomechanical grip strength, pinch strength, and range of wrist movements.”

Does not settle: Источник не проверяет адресные аутологичные микротрансплантаты, их клеточный состав или нервное соединение, карту связей, пороги 10% и 1% в год, минимальное число участков либо восстановление функции через сеть сохранённых тканей.

S9BackgroundAbstract only

The Treatment of Complex Extremity Wounds Using External Tissue Expansion: A Case Series. · Plastic and reconstructive surgery · 2023

“Comparatively, tissue expansion can provide the opportunity to reconstruct large wounds with native, durable, and sensate tissue without significant donor site morbidity.”

Does not settle: Источник не оценивает адресные аутологичные микротрансплантаты, состав клеток и придатков, восстановление нервных связей, карту связей, порог 10% объёма, ежегодное повторное замещение или достаточность минимального набора участков.

S10Background

Complex Wound Closure Following Mysterious and Vicious Animal Attack. · Cureus · 2020

“She was seen regularly in the outpatient setting for several months, where her STSG was noted to have 100% take, and her donor site showed appropriate healing”

Does not settle: Источник описывает один случай закрытия травматической раны дермальным регенерационным шаблоном и расщеплённым кожным трансплантатом. Он оставляет открытыми состав и размер микротрансплантатов, выбор участков по карте связей, пороги 10% и 1%, восстановление придатков и нервных связей, а также достаточность такого подхода для совместной функции кожи.

The gap this hypothesis explains

Nothing is known here: the question has not been asked of this system.

Which smallest treatment and maintenance combinations keep all skin functions youthful in the same people for ten years?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Какие минимальные сочетания воздействий и выдержат и сравнение со , сохранив у одних участников все функции кожи в молодом диапазоне на десять лет?

What this question is asking

The question concerns restoring middle-aged people's skin function to the range found in young people and maintaining that result. It asks which combinations of treatments and continuing care achieve this for every required function together in the same individuals for at least ten years, compared with standard care. Participants would be assigned by chance to combinations with particular components removed, so the comparison could establish which components are needed. The question assumes that existing work shows only partial effects and has not established a sufficient combination; however, the supplied material does not define the complete list of functions, their , standard care, or the additional conditions referenced in the gap description.

What the terms mean
Youthful range
The range of measured skin function taken to represent young people. It would require defined measurements and reference values; none are supplied, and youthfulness is not a single yes-or-no property.
All skin functions
The complete set of skin abilities required by the question, achieved together in the same individuals. The input does not enumerate them, so selected measurements cannot be treated as the complete set.
Maintenance regimen
The continuing treatment or care schedule intended to preserve an initial result. The supplied sources do not establish such a schedule for the requested ten-year outcome.
Standard care
The usual care against which a treatment combination would be compared. Its content is not defined in the input, and it is not automatically equivalent to placebo or to another active treatment.
Randomized component removal
Assigning participants by chance to a complete combination or to versions missing particular components. This comparison addresses whether each component contributes to achieving the specified outcome.
Necessary, sufficient, and smallest combination
A necessary component is needed for the specified result under the tested conditions; a sufficient combination achieves that result. A smallest sufficient combination achieves it without dispensable components, although different sufficient combinations could exist.
Placebo
A comparison preparation intended to resemble treatment without its active ingredient. A placebo comparison does not by itself establish superiority to standard care.
Collagen, hydrolyzed collagen, and collagen tripeptide
Collagen is a structural protein. Hydrolyzed collagen consists of smaller protein fragments, while collagen tripeptides are fragments containing three amino-acid building blocks; the supplied studies examine these as swallowed supplements.
Skin hydration and elasticity
Hydration describes skin water content, and elasticity describes its ability to recover after deformation. They are separate measured properties, not a complete definition of skin function.
Skin aging and skin rejuvenation
These broad labels describe age-associated skin changes and attempts to improve them. Different studies can measure different features under these labels, so they do not identify a single standardized outcome.
Microneedle fractional radiofrequency
A treatment using fine needles to deliver radiofrequency energy to selected areas of skin. In S6, it is the treatment used in both comparison groups.
Basic fibroblast growth factor
A signaling protein associated with cell growth, including cells that produce supporting tissue. In S6, it is the added component whose contribution is compared.
Microfocused ultrasound and delicate pulsed light
The sound-energy and light-based treatments combined in S7. That study compares their combination with ultrasound alone on opposite sides of participants' faces.
Hyaluronic acid serum
A preparation applied to skin containing a water-binding substance. In S10, it is added to an existing treatment rather than tested as a complete skin-restoration combination.
Botulinum toxin type A
An injected substance that reduces muscle activation and is used to treat some facial lines. In S10, both comparison groups receive it.
Statistical significance
A convention for judging how compatible an observed difference is with a specified model of chance variation. A statistically significant change within each treatment group does not establish a statistically significant difference between treatments.
What the question takes for granted
Premise only partly supported
Existing work describes partial effects, but the sufficiency of treatment combinations for maintaining all skin functions in a for at least ten years has not been experimentally established.

The assumption is that available treatments have changed selected features of skin, but no tested combination has demonstrated the complete, lasting result. That distinction would make the unresolved issue the smallest combination capable of achieving the whole result, rather than whether any individual skin measurement can improve.

S1 and S3 report improvements in selected skin measurements over short periods, and S7 reports changes in facial wrinkles after six months. S6 and S10 describe comparisons that add one treatment to another, but their supplied excerpts do not establish the complete outcome. S2 also disputes the clinical support for collagen supplements. These sources support a narrower statement: the supplied evidence concerns selected outcomes and does not establish the requested ten-year result. They cannot establish that no sufficient combination has been demonstrated anywhere in the literature, and the pipeline's internal evidence categories are not defined.S1S2S3S6S7S10

The same question asked without the part nothing read establishes:

  • Which smallest combinations of treatments and continuing care, compared with standard care and with individual components removed by random assignment, maintain all specified skin functions within defined in the same middle-aged participants for ten years?
  • What do the supplied studies establish about the contribution of individual treatments within combinations, and about how long their measured skin effects last?
What turns on the answer
  • A smallest sufficient combination is established A combination would meet the complete ten-year outcome against standard care, while removing any retained component would prevent that outcome. Within the combinations and participants tested, this would support both the adequacy of the complete combination and the need for each retained component.
  • The complete result survives component removal If the full result persisted after a component was removed, that component would not be necessary under those tested conditions. The original combination would therefore not be the smallest sufficient option, even if it worked.
  • Only partial or temporary improvement occurs Some measurements could improve while other required functions remained outside , or the improvement could end before ten years. Such a combination would not satisfy the question's complete outcome, regardless of how useful its narrower effects might be.
  • No qualifying advantage over standard care appears If a combination did not establish the required outcome relative to standard care, its added treatments would lack demonstrated benefit for this particular goal. That result would apply to the tested combination and conditions, without ruling out every possible combination.
Why it matters

Improvement in one skin measurement does not establish that every required function has reached a . Even if a combination achieved the complete result, that alone would not show whether every component was needed. Removing components and comparing the resulting outcomes addresses that separate question, while comparison with standard care addresses what the combination adds to existing care. Confusing these steps could lead to unnecessary treatment or to describing a short-term, limited improvement as lasting restoration of skin function.

What is already established

Клеточные, и S-узлы уровня RL-1/RL-2 описывают частичные эффекты; достаточность сочетаний экспериментально не установлена.

What would have to be true

Установленный набор вариантов, обеспечивающих совместный молодой функциональный диапазон минимум десять лет при выполнении остальных условий Q0.

What is missing

Неизвестно, какие компоненты совместно необходимы и достаточны, и воспроизводится ли после исключения любого из них.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Минимальный набор составляет адресное замещение небольшого числа полноценными . Каждый включает , , , клетки , соответствующих анатомической области, и структуры для соединения с . Места выбирают на разрывах связей между сохранившимися функциональными участками , и . Количественная гипотеза: суммарный объём пересаженной ткани не превышаетобъёма кожи каждой исследуемой области; точное минимальное число участков n* определяется её картой связей. Остальные не менееткани сохраняются. состоит из ежегодной оценки функции и повторного замещения только участков с подтверждённой утратой соединения, суммарно не болееисходного объёма области в год. Предполагается, что этого достаточно для восстановления совместной функции через включение сохранившихся тканей в общую работающую сеть. Меньший набор недостаточен, если удаление хотя бы одного выбранного участка оставляет функционально изолированную территорию. Сплошное восстановление возрастного не требуется.

Where the idea comes from

The hypothesis borrows a result from another field. This is what it borrows, and from where.

. Используется конечная задача восстановления : S* = (i∈S)v_i при ограничениях |C_mut(G⊕S)|/N ≥ q и (i∈S)v_i/V ≤ 0,10; n* = |S*|. Здесь G — измеренная тканевых участков; её слои описывают отдельно непрерывность , и функциональные ; S — выбранные участки замещения; i — один такой участок; v_i — объём его ; V — объём кожи исследуемой области; G⊕S — сеть после фактически подтверждённого восстановления участков и их связей; C_mut — множество участков, взаимно соединённых в каждом обязательном слое; N — общее число ; q — заранее установленная требуемая доля охвата; S* — набор минимального объёма; n* — число его участков. q определяют на до проверки лечения. Источник математического подхода: [Optimal on ](https://www.nature.com/articles/s41467-017-01442-2). Применение к коже является предлагаемым переносом. сама по себе не доказывает функции: биологические связи и совместный функциональный ответ проверяются независимо.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

При одинаковых составе и суммарном объёме размещение в заранее определённых восстанавливает совместную функцию всей исследуемой области, включая непересаженную ткань. Случайное размещение и размещение в наиболее повреждённых, но этого результата не дают. Исключение критического вызывает ухудшение на территории, существенно превышающей его площадь, тогда как исключение такого же объёма из сохраняет результат. Если улучшение ограничивается площадью пересаженной ткани либо определяется только суммарным объёмом, гипотеза опровергнута. Полное восстановление после одного при сохранении предполагаемых разрывов также опровергает необходимость этого набора.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable functional and spatial outcomes, placement and removal comparisons, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Первую проверку можно провести в : сравнить одинаковые при целевом и случайном размещении и проверить распространение функционального эффекта. Полноценный человеческий со всеми указанными , и пока нельзя считать готовой технологией. Поэтому современная выполнимость относится к и отдельных составов; всего набора остаётся открытой.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

При одинаковых составе и суммарном объёме размещение в заранее определённых восстанавливает совместную функцию всей исследуемой области, включая непересаженную ткань. Случайное размещение и размещение в наиболее повреждённых, но этого результата не дают. Исключение критического вызывает ухудшение на территории, существенно превышающей его площадь, тогда как исключение такого же объёма из сохраняет результат. Если улучшение ограничивается площадью пересаженной ткани либо определяется только суммарным объёмом, гипотеза опровергнута. Полное восстановление после одного при сохранении предполагаемых разрывов также опровергает необходимость этого набора.

  • What would separate them

    Restoring collagen, elastin networks and basement membranes may restore youthful skin function predicts: Полный обеспечивает совместное восстановление SPV_1-SPV_8, включая чувствительность и согласованную теплоотдачу, при сохранении собственных участника. до начального курса снижает долю ниже заранее установленной границы. Добавление клеточных не улучшает результат больше заранее заданной . После завершения курса отсутствие специальной не приводит к утрате . Устойчивое сохранение дефекта чувствительности или потоотделения при подтверждённом восстановлении всех трёх структур опровергает достаточность этого набора и поддерживает соперника, предусматривающего .

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

3 quantitative figures appear below and the hypothesis cites no study for any of them. They are the engine's own, and the marks in the text say which.

CitationsCites nothingFigures3 of 3 uncarriedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.